| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fad57abc23a66d5aafc44913546f294e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e202c822e51ed393262aa4a38d233869
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ff2f32edc579ac7cec781aa03ae2fc4b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d3e23273c41112835578240aabacfd5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4338d82ac3c1fda25be25f07a6aeed2d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb00d6193d004798d183effb04c6bebb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_91482ddd3a59d7d19e1de02a9c9daddd |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-51 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6803
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5041
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-538 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate |
2009-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3be2c638dcffb962e5a76b8ddc182a8d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21530fb47dee5edc20a4ed2e166a2c3f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cce260dc45e023edc764f6521661cdad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d8552ed03401589dd8f6c5e7fcc672d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd6808a90ce0c22f47218f9316ebda73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e6d0e444eb20c5d0d47a55693ba67b5 |
| publicationDate |
2010-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2010019878-A1 |
| titleOfInvention |
Methods for identifying compounds which inhibit binding of anthrax protein to lrp5/6 receptors. |
| abstract |
The present invention identifies compounds that disrupt the interaction between anthrax proteins and LRP5/6 receptors, resulting in a reduction in anthrax toxicity. The compounds act to disrupt the intracellular transport of toxin complexes into a target cell. The present invention also provides methods for testing the effect of compounds on Wnt activity, through the use of in vitro experiments involving cells that have in at least one gene mutation involved in the Wnt pathway. |
| priorityDate |
2008-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |